Treasurer of the State of North Carolina Purchases 70 Shares of Chemed Co. (NYSE:CHE)

Treasurer of the State of North Carolina lifted its position in Chemed Co. (NYSE:CHEFree Report) by 1.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,720 shares of the company’s stock after acquiring an additional 70 shares during the period. Treasurer of the State of North Carolina’s holdings in Chemed were worth $3,930,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in CHE. GAMMA Investing LLC purchased a new position in shares of Chemed in the 4th quarter worth $37,000. Principal Securities Inc. bought a new position in shares of Chemed during the fourth quarter worth $51,000. SRS Capital Advisors Inc. raised its stake in Chemed by 110.6% during the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock valued at $58,000 after purchasing an additional 52 shares in the last quarter. Covestor Ltd increased its stake in Chemed by 27.4% during the third quarter. Covestor Ltd now owns 144 shares of the company’s stock worth $75,000 after acquiring an additional 31 shares during the last quarter. Finally, Larson Financial Group LLC increased its position in shares of Chemed by 86.9% during the 4th quarter. Larson Financial Group LLC now owns 157 shares of the company’s stock valued at $92,000 after purchasing an additional 73 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on CHE. Oppenheimer increased their price target on Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Thursday, February 29th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Finally, Royal Bank of Canada reduced their price target on shares of Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 21st.

Read Our Latest Report on CHE

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 4,000 shares of Chemed stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $567.54, for a total value of $2,270,160.00. Following the transaction, the chief executive officer now owns 108,549 shares of the company’s stock, valued at approximately $61,605,899.46. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CEO Kevin J. Mcnamara sold 4,000 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the completion of the sale, the chief executive officer now owns 108,549 shares in the company, valued at approximately $61,605,899.46. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Brian C. Judkins sold 11,158 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total value of $7,196,910.00. Following the completion of the sale, the vice president now directly owns 1,422 shares of the company’s stock, valued at approximately $917,190. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 19,808 shares of company stock worth $12,454,691. 3.32% of the stock is owned by corporate insiders.

Chemed Price Performance

CHE stock opened at $548.91 on Wednesday. Chemed Co. has a 1-year low of $492.84 and a 1-year high of $654.62. The business has a 50-day moving average price of $589.16 and a 200 day moving average price of $593.79. The company has a market capitalization of $8.31 billion, a P/E ratio of 29.53, a PEG ratio of 2.26 and a beta of 0.46.

Chemed (NYSE:CHEGet Free Report) last released its quarterly earnings data on Wednesday, April 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). The business had revenue of $589.23 million for the quarter, compared to the consensus estimate of $587.18 million. Chemed had a net margin of 12.36% and a return on equity of 30.52%. On average, analysts anticipate that Chemed Co. will post 21.72 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 18th. Investors of record on Thursday, May 30th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.29%. The ex-dividend date is Thursday, May 30th. Chemed’s payout ratio is currently 8.61%.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.